List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 21 studies with search of: Open Studies | "Hemorrhagic Fevers, Viral"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany
Condition: Hemorrhagic Fever With Renal Syndrome
Intervention: Drug: Virazole (Ribavirin)
2 Recruiting Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus
Condition: Dengue Hemorrhagic Fever
Interventions: Biological: rDEN1delta30;   Biological: rDEN2/4delta30(ME);   Biological: Placebo to rDEN1delta30 or rDEN2/4delta30(ME)
3 Recruiting Efficacy and Safety of Dengue Vaccine in Healthy Children
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Diseases
Interventions: Biological: Chimeric tetravalent dengue (serotype 1, 2, 3, 4);   Biological: Inactivated Rabies virus vaccine
4 Recruiting Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America
Conditions: Dengue;   Dengue Hemorrhagic Fever;   Dengue Virus;   Dengue Fever
Interventions: Biological: CYD Dengue Vaccine;   Biological: Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis
5 Recruiting Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Virus;   Dengue Diseases
Interventions: Biological: CYD Dengue vaccine;   Biological: NaCl + influenza virus or hepatitis A vaccine
6 Recruiting A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Shock Syndrome
Intervention: Biological: Tetravalent live attenuated dengue vaccine
7 Not yet recruiting Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus
Conditions: Dengue Virus Infection;   Dengue Hemorrhagic Fever/ Shock Syndrome (DHF/DSS);   Dengue Fever
Interventions: Biological: DEN4 Vaccine Candidate;   Biological: DEN4 Vaccine Placebo
8 Recruiting Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31‐7164) in Healthy Adults
Condition: Dengue Fever
Intervention: Biological: rDEN3delta30/31‐7164
9 Recruiting Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN3/4delta30(ME);   Biological: Placebo
10 Recruiting Study of HBV-001 D1 in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: DEN1-80E (HBV-001 D1 + 3.5 mg Alhydrogel);   Biological: Placebo for DEN1-80E
11 Recruiting Safety of and Immune Response of a 2-Dose Regimen of rDEN1delta30 Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: rDEN1delta30;   Biological: Placebo
12 Recruiting Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: rDEN4delta30-200,201;   Biological: Placebo
13 Recruiting Prospective Study of Infant Dengue
Condition: Dengue
Intervention:
14 Recruiting Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine
Condition: Dengue Fever
Interventions: Biological: rDEN2/4delta30(ME) vaccine;   Biological: Placebo
15 Not yet recruiting Diagnosis and Characterization of Dengue Fever in Children
Condition: Dengue Fever
Intervention:
16 Recruiting Follow-up the Health Condition , Investigation of the Immuno-Regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection
Condition: Dengue
Intervention: Genetic: dengue fever
17 Recruiting A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand
Condition: Dengue
Intervention: Biological: Live attenuated tetravalent dengue vaccine
18 Recruiting Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Condition: Dengue Fever
Intervention: Genetic: CLEC5A
19 Not yet recruiting Evaluating an Ebola and a Margurg Vaccine in Uganda
Conditions: Ebola Virus Disease;   Marburg Virus Disease
Interventions: Biological: Ebola vaccine;   Biological: Marburg vaccine;   Other: Placebo injection
20 Not yet recruiting Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
Condition: Rift Valley Fever
Intervention: Biological: Inactivated, Dried (TSI-GSD 200), RVF Vaccine

Previous Page Studies Shown (1-20) Next Page (21-21)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services